Translational Genomics Research Institute
33°27′10.68″N 112°4′1.83″W / 33.4529667°N 112.0671750°W
| Company type | Research Institute |
|---|---|
| Industry | Genomics |
| Founded | July 2002, Phoenix, Arizona, United States |
| Headquarters | Phoenix, Arizona, United States |
Key people | Jeffrey Trent |
| Website | http://www.tgen.org |
The Translational Genomics Research Institute (TGen), is a non-profit genomics research institute established in 2002 by Jeffrey Trent, the founding Scientific Director of the National Human Genome Research Institute (NHGRI), in Phoenix, Arizona, United States.
TGen seeks to employ genetic discoveries to improve disease outcomes by developing smarter diagnostics and targeted therapeutics.
TGen conducts research on a number of human disorders including Alzheimer's disease, Autism, Parkinson's, Diabetes and numerous forms of cancer and a variety of other complex human diseases. This internationally recognized institute has helped to generate a strong foundation for Arizona's growing role in scientific research and cutting edge biotechnology.
The emerging field of translational genomics research harnesses the power of new discoveries resulting from the Human Genome Project and applying them to the development of improved diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.
Affiliated Organizations
TD2 - TGEN Drug Development, LLC - contract research organization focusing on cancer research
TGen in the news
- International TGen-led team finds link between brain protein and Alzheimer's disease
- 'Dramatic results' for cancer drug; tumors shrinking, TGen researchers report
- Cancer-drug trials show promise
- 5-year-old TGen Fights for Funding
- Research Team Identifies Human 'Memory Gene'
- TGen may have found Lou Gehrig's trigger
- Study finds big impact on economy from TGen
- A look at future of biosciences
- Scientist pushes genome knowledge
- Personalized medicine links treatment to genetics
TGen Administration
- Jeffrey M. Trent, Ph.D., President & Scientific Director
- Michael Bassoff, President, TGen Foundation
- Daniel Von Hoff, M.D., F.A.C.P., Executive Vice President, Physician-in-Chief
- Tess Burleson, MBA, CPA, Chief Operating Officer and President, TGen Accelerators
- Chuck Coleson, Chief Financial Officer
- Galen Perry, Vice President, Marketing and Communications
- Janine Tilli, Vice President, Human Resources
External links
 | This genetics article is a stub. You can help Wikipedia by expanding it. |